This supplemental report is being submitted to provide a correction to the previously reported event.The lot number originally reported (138199) is the device lot for kit lot 144070.Further review of the case determined that the corresponding patient swab lots for outer kit lot 144070 are as follows: p0243, p0223, p0177.
|
This supplemental report is being submitted to provide the investigation conclusion.Please see updates: inspections were performed at abbott diagnostics scarborough, inc.On retained kit lot 144070 for damaged patient swabs.All blank patients swabs under lots p0177, p0223, and p0243 were inspected.No damaged swabs were observed.Swabs were not scored and could only be broken after repeated bending back and forth.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-160 / lot: 144070.The lot met the required release specifications.The manufacturing batch records were also reviewed for component part number pk002545 / lots p0243, p0223, and p0177; the lots met the required release specifications.A review of the complaints reported as defective patient swabs related to kit lot 144070 showed that the complaint rate is (b)(4).The reported issue is anticipated in nature and severity for the binaxnow covid-19 antigen self-test according to risk documentation.No new hazard has been identified.In conclusion, abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue, however, it could be related to issues such as the self-test user performance.
|